The new Novel Corona virus-cured disease will prevent the blood of cured 19 from treating critically ill patients, as well as others.
This was revealed in a US medical study.
Scientists at the Washington University School of Medicine are currently awaiting government approval to test the blood plasma of patients who have defeated the disease to see how it helps improve the immune system.
This method was used during the Spanish flu outbreak of 1918, before a vaccine or antiviral drugs were available.
This procedure is based on the fact that healthy patients have powerful antibodies in their blood that are trained to fight the virus.
Be aware that there is currently no cure for the new nasal coronavirus, while the availability of the vaccine may not be possible until the end of this year or the first half of next year.
According to Dr. Jeffrey Henderson, Associate Professor at the University of Washington, the use of serum from the blood of recently recovered patients may seem old-fashioned, but historically it has been useful.
“By using it we have been able to prevent and treat virus infections such as measles, polio, and influenza, but once the vaccine is developed, this technique has been forgotten,” he added.
“As long as COVID-19 produces specific drugs and vaccines, this method will help save lives,” he said.
Doctors did not have any treatment during the Spanish flu outbreak, so they helped many people recover by using blood serum to recover patients.
Blood plasma and serum are made of transparent blood fluid and both are equipped with antibodies, but plasma contains some other helpful proteins that are not present in the serum.
This method was used experimentally to treat the SARS Coronavirus epidemic in 2002 and 2003.
The SARS virus is said to be similar to the new Coronavirus, but it is also called SARS Corona Virus 2.
During the SARS epidemic, a study found that patients who were given blood plasma returned to health faster than others.
Prior to Washington University, Johns Hopkins University and Mayo Clinic also started trials on this method with regard to COVID-19.
His recommendations were submitted March 18 to the Food and Drug Administration of the United States and he is awaiting permission to try them on humans.
Dr. Jeffrey Anderson said that this is a step that needs to be taken urgently; it is faster than drug preparation because it will require plasma donation and transplantation.
He said, “As soon as someone heals around COVID-19 and he revolves around us, he will be a potential donor to us.” and we will use the Bloodbank system to obtain plasma and distribute it to patients in need, if this method works, it will provide a lifeline in the early stages of this outbreak. ‘
The research team is now requesting blood donations from healthy patients, out of which the haloesma will be isolated and transmitted to ill persons after a screening of toxic material and viruses.
Report on A Century-Old Way Attempt To Defeat The Coronavirus